Biotech

Proteomics International Laboratories Ltd (ASX:PIQ) New Blood Test For Endometriosis Moves Closer to Market

🕔5/30/2025 12:34:20 PM

Proteomics International Laboratories Ltd (ASX:PIQ) has unveiled landmark clinical data confirming its Promarker(R)Endo blood test as a highly accurate, non-invasive diagnostic tool for endometriosis.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerEndo Latest Results Presented at World Congress

🕔5/26/2025 8:21:24 AM

Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, is pleased to announce another milestone in the development of its PromarkerEndo diagnostic test for endometriosis.

Read Full Article

AFT Pharmaceuticals Limited (ASX:AFP) Sees Strong FY 26 as Revenue Reaches New Record

🕔5/22/2025 10:34:31 AM

AFT Pharmaceuticals Limited (NSX:AFT) (ASX:AFP) today reports it has again achieved another year of record revenue with annual sales exceeding $200 million1 and it is now firmly focused on its revenue target of $300 million by the end of the 2027 financial year.

Read Full Article

Ellis Martin Report: GT Biopharma Inc's (NASDAQ:GTBP) Michael Breen: Targeting Cancer Cells with a Natural Killer Based Immunotherapy

🕔5/19/2025 11:00:00 PM

In this compelling episode of The Ellis Martin Report, host Ellis Martin engages in a powerful and enlightening conversation with Michael Breen, CEO and Managing Director of GT Biopharma Inc. (NASDAQ:GTBP).

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) Chinese Patent Granted for OxiDx Technology

🕔5/15/2025 9:13:09 AM

Proteomics International Laboratories Ltd ((ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, is pleased to announce that its subsidiary OxiDx Pty Ltd, has secured new intellectual property protection following the grant of a patent in China for the platform technology which precisely measures levels of oxidative stress.

Read Full Article

Osteopore Limited (ASX:OSX) Elevates Partnership with Kelyniam for the U.S. Craniofacial Market

🕔5/12/2025 4:35:33 PM

Australian-Singaporean regenerative medicine company Osteopore Limited (ASX:OSX) is pleased to announce that the Company has secured a non-exclusive 3-year distribution arrangement with Kelyniam Global, Inc

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) Share Purchase Plan Offer Booklet

🕔5/5/2025 10:24:05 AM

On 22 April 2025, Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF) announced that it will be conducting a placement of 10,810,811 fully paid ordinary shares in the Company at an issue price of $0.37 per Share to sophisticated, institutional and professional investors, raising approximately $4 million.

Read Full Article